4.95

0.20% 0.010

After Hours: 4.95

Maravai Lifesciences Holdings Inc (MRVI)

Overview News Price History Option Chain Financials Why MRVI Down? Discussions Forecast

Maravai Lifesciences Holdings Inc stock is traded at $4.95, with a volume of 1.02M. It is up +0.20% in the last 24 hours and down -16.81% over the past month. Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Previous Close:

$4.94

Open:

$4.99

24h Volume:

1.02M

Relative Volume:

0.51

Market Cap:

$702.13M

Revenue:

$288.95M

Net Income/Loss:

$-119.03M

P/E Ratio:

-5.4969

EPS:

-0.9005

Net Cash Flow:

$60.67M

1W Performance:

-1.98%

1M Performance:

-16.81%

6M Performance:

-45.54%

1Y Performance:

-10.65%

1-Day Range:

$4.83

$5.03

1-Week Range:

$4.71

$5.19

52-Week Range:

$4.275

$11.55

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name

Maravai Lifesciences Holdings Inc

Sector

Healthcare (1177)

Industry

Biotechnology (679)

Phone

(858) 546-0004

Address

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Employee

580

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

MRVI's Discussions on Twitter

Compare MRVI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MRVI Maravai Lifesciences Holdings Inc	4.95	702.13M	288.95M	-119.03M	60.67M	-0.9005
VRTX Vertex Pharmaceuticals Inc	481.16	123.91B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	722.07	78.94B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	657.97	39.98B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	278.25	35.89B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	119.94	28.75B	3.30B	-501.07M	1.03B	-2.1146

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-19-24	Initiated	Guggenheim	Neutral
Dec-05-24	Downgrade	Goldman	Neutral → Sell
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Nov-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-24	Initiated	Wells Fargo	Overweight
Aug-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-10-24	Initiated	Craig Hallum	Buy
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Aug-05-21	Resumed	Credit Suisse	Outperform
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-15-20	Initiated	BofA Securities	Buy
Dec-15-20	Initiated	Credit Suisse	Outperform
Dec-15-20	Initiated	Goldman	Buy
Dec-15-20	Initiated	Jefferies	Buy
Dec-15-20	Initiated	Robert W. Baird	Outperform
Dec-15-20	Initiated	Stifel	Buy
Dec-15-20	Initiated	William Blair	Outperform
Dec-14-20	Initiated	UBS	Buy

View All

Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News

Feb 06, 2025

A Look at Maravai LifeSciences Holdings Inc (MRVI) Shares in the Recent Past Indicates Growth - SETE News

Feb 06, 2025

Maravai LifeSciences Target of Unusually High Options Trading (NASDAQ:MRVI) - Defense World

Feb 06, 2025

Stock Traders Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat

Feb 06, 2025

Feb 05, 2025

Brokerages Set Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) PT at $10.28 - MarketBeat

Feb 05, 2025

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Consensus Rating of “Hold” by Analysts - ETF Daily News

Feb 05, 2025

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Brokerages - Defense World

Feb 05, 2025

Understanding the 8.92% Volatility Levels of Maravai LifeSciences Holdings Inc’s (MRVI) Stock in the Past 30 Days - The News Heater

Feb 05, 2025

Feb 04, 2025

TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology - Marketscreener.com

Feb 04, 2025